Nasdaq Tumbles 2%; Pliant Therapeutics Shares Spike Higher

U.S. stocks traded lower midway through trading following the release of jobs report on Friday.

The Dow traded down 0.50% to 31,180.09 while the NASDAQ fell 2.08% to 11,392.80. The S&P also fell, dropping, 1.15% to 3,854.54.

Also check this: GameStop, Levi Strauss And 3 Stocks To Watch Heading Into Friday

Leading and Lagging Sectors

Health care shares slipped by just 0.2% on Monday. Meanwhile, top gainers in the sector included Pliant Therapeutics, Inc. PLRX, up 113% and Nyxoah S.A. NYXH up 11%.

In trading on Monday, communication services shares dipped by 2.3%.

Top Headline

AZZ Inc AZZ reported better-than-expected earnings for its first quarter on Monday.

AZZ reported first-quarter FY23 sales growth of 36.8% year-over-year to $314.4 million, beating the consensus of $268.09 million. Adjusted EPS jumped 59.1% Y/Y to $1.40, beating the consensus of $1.03.

Equities Trading UP

Pliant Therapeutics, Inc. PLRX shares shot up 114% to $19.00 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.

Shares of La Jolla Pharmaceutical Company LJPC got a boost, shooting 81% to $6.14 after Innoviva entered into a definitive agreement to acquire the company for $5.95 per share and an incremental $0.28 per share for additional cash proceeds, or an implied enterprise value of approximately $149 million.

Iterum Therapeutics plc ITRM shares were also up, gaining 72% to $0.4116 after the company announced that it has reached an agreement with the FDA under the special protocol assessment process on the design, endpoints and statistical analysis of a Phase 3 clinical trial for oral sulopenem etzadroxil-probenecid to begin in Q4.

Equities Trading DOWN

Fastly, Inc. FSLY shares tumbled 14% to $11.56 after Morgan Stanley downgraded the stock from Equal-Weight to Underweight and lowered its price target from $18 to $12.

Shares of Freeline Therapeutics Holdings plc FRLN were down 20% to $0.8875. Freeline Therapeutics announced the presentation of safety and initial efficacy data from the first cohort of the Phase 1/2 B-LIEVE trial for FLT180a for hemophilia B.

DigitalOcean Holdings, Inc. DOCN was down, falling 14% to $39.84 after analysts at Morgan Stanley downgraded their rating of the stock from Equal-Weight to Underweight.

Also check out: This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday


In commodity news, oil traded down 1.1% to $103.60, while gold traded down 0.3% to $1,736.60.

Silver traded down 0.5% to $19.145 on Monday while copper fell 2.8% to $3.4220.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 0.55%, London’s FTSE 100 fell 0.14% while Spain’s IBEX 35 Index fell 0.43%. The German DAX declined 1.42%, French CAC 40 fell 0.72% and Italy’s FTSE MIB Index fell 0.87%.


The Treasury will also auction 3-year notes at 1:00 p.m. ET.

Federal Reserve Bank of New York President John Williams will speak at 2:00 p.m. ET.

Check out this: U.S. Jobs Growth Might Slow To This Level In June, Here's The Major Macro Issues For Friday

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 90,065,160 cases with around 1,045,080 deaths. India confirmed a total of at least 43,587,300 cases and 525,340 deaths, while Brazil reported over 32,761,040 COVID-19 cases with 673,120 deaths. In total, there were at least 558,810,440 cases of COVID-19 worldwide with more than 6,369,440 deaths.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Day Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!